Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T04820
|
||||
Former ID |
TTDR00301
|
||||
Target Name |
Cyclin-dependent protein kinase Pfmrk
|
||||
Gene Name |
Pfmrk
|
||||
Synonyms |
MO15-related protein kinase Pfmrk; Pfmrk
|
||||
Target Type |
Research
|
||||
Disease | Malaria [ICD10: B54] | ||||
BioChemical Class |
Kinase
|
||||
Target Validation |
T04820
|
||||
UniProt ID | |||||
EC Number |
EC 2.7.1.37
|
||||
Sequence |
MENNSTERYIFKPNFLGEGSYGKVYKAYDTILKKEVAIKKMKLNEISNYIDDCGINFVLL
REIKIMKEIKHKNIMSALDLYCEKDYINLVMEIMDYDLSKIINRKIFLTDSQKKCILLQI LNGLNVLHKYYFMHRDLSPANIFINKKGEVKLADFGLCTKYGYDMYSDKLFRDKYKKNLN LTSKVVTLWYRAPELLLGSNKYNSSIDMWSFGCIFAELLLQKALFPGENEIDQLGKIFFL LGTPNENNWPEALCLPLYTEFTKATKKDFKTYFKIDDDDCIDLLTSFLKLNAHERISAED AMKHRYFFNDPLPCDISQLPFNDL |
||||
Inhibitor | (E)-1-(4-Nitro-phenyl)-3-pyridin-2-yl-propenone | Drug Info | [527246] | ||
2,5-dichloro-N-p-tolylthiophene-3-sulfonamide | Drug Info | [551239] | |||
2,5-dichloro-N-phenylthiophene-3-sulfonamide | Drug Info | [551239] | |||
2-chloro-N-(o-tolylcarbamoyl)benzamide | Drug Info | [551239] | |||
3-[3-(2-Hydroxy-ethoxy)-phenyl]-1H-quinolin-2-one | Drug Info | [527246] | |||
5-chloro-4-nitrothiophene-2-sulfonamide | Drug Info | [551239] | |||
5-Nitro-1H-indole-2,3-dione | Drug Info | [527246] | |||
APIGENIN | Drug Info | [527246] | |||
KENPAULLONE | Drug Info | [527246] | |||
N'-(2-fluorobenzoyl)-2-naphthohydrazide | Drug Info | [551239] | |||
N-(2-aminoethyl)isoquinoline-5-sulfonamide | Drug Info | [528918] | |||
Oxindole derivative | Drug Info | [536365] | |||
Thiophene sulfonamide | Drug Info | [536636] | |||
WR-080539 | Drug Info | [529988] | |||
WR-089120 | Drug Info | [529988] | |||
WR-190706 | Drug Info | [529988] | |||
WR-203581 | Drug Info | [529988] | |||
WR-289009 | Drug Info | [529988] | |||
WR-289010 | Drug Info | [529988] | |||
WR-289012 | Drug Info | [529988] | |||
WR-289016 | Drug Info | [529988] | |||
References | |||||
Ref 527246 | J Med Chem. 2004 Oct 21;47(22):5418-26.A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors. | ||||
Ref 528918 | Bioorg Med Chem Lett. 2007 Sep 1;17(17):4961-6. Epub 2007 Jun 12.Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk. | ||||
Ref 529988 | Bioorg Med Chem Lett. 2009 Apr 1;19(7):1982-5. Epub 2009 Feb 13.Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones. | ||||
Ref 536365 | Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents. 2007 Jul;30(1):4-10. Epub 2007 Mar 6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.